Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Alzheimer's Disease THErapy With NEuroaid II

ATHENE II is a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial designed to evaluate the efficacy and safety of MLC901 in subjects with mild to moderate Alzheimer's disease, as well as its effects on plasma biomarkers compared to placebo.

Participants needed: 350
Trial details
Phase: Phase 3Age: 50+Biological sex: AllType: InterventionalSponsor: Moleac Pte Ltd.Updated: Jun 12, 2026Locations: 1
Eligibility criteria

Male or female subjects aged ≥ 50 years at the time of providing informed consen... [+6]

Presence of any neurological disorder contributing to cognitive impairment other... [+9]

Read more
Status: Not yet recruiting

MLC1501 Study Assessing Efficacy in STROke Recovery

This is a multi-center, randomized, double-blind, placebo-controlled, dose-response study of MLC1501 in patients with stroke. Eligible participants will be randomized in a 1:1:1 ratio to orally receive MLC1501 low-dose twice a day, MLC1501 high-dose twice a day, or matching placebo for 24 weeks.

Participants needed: 540
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Moleac Pte Ltd.Updated: Mar 16, 2023
Eligibility criteria

Male or female. [+5]

Pre-stroke modified Rankin score of >1. [+8]

Read more